Targeting Neurodegeneration in Alzheimer’s Disease: A Comprehensive Evaluation of Andrographolide as a Potential Therapeutic Agent in the Management and Treatment of Cognitive Decline. JIMP [Internet]. 2024 Aug. 25 [cited 2026 Feb. 27];1(02):20-32. Available from: https://sennosbiotech.com/JIMP/1/article/view/24